MAD Study of NX210c

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study will investigate the safety and tolerability of multiple intravenous infusions of NX210c with two ascending doses as well as NX210c pharmacokinetics (PK), and pharmacodynamics (PD) effects, firstly in healthy elderly subjects, and the recommended dose to be used for Alzheimer\'s disease patients, in a second step.
Epistemonikos ID: f62211e1b027080291a21eb7c4843b147332e9d7
First added on: Feb 19, 2024